Andrew Saik Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Andrew Saik.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andrew Saik. Andrew Saik is a CFO in AUXILIUM PHARMACEUTICALS INC ($AUXL) and a Chief Financial Officer in Edge Therapeutics, Inc. ($EDGE) and a Chief Financial Officer in Menlo Therapeutics Inc. ($MNLO).
Address: 640 LEE ROAD CHESTERBROOK 19087 PA
Companies in which Andrew Saik is an Insider
AUXILIUM PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andrew Saik: CFO
Holdings: 0 shares
Latest Transaction: Jan 30 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PDS Biotechnology Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andrew Saik: Chief Financial Officer
Holdings: 82,999 shares
Current Value: $792,640
Latest Transaction: Jun 07 2019
$EDGE Market Capitalization: $272.98M
$EDGE Previous Close: $9.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VYNE Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andrew Saik: Chief Financial Officer
Holdings: 113,451 shares
Latest Transaction: Apr 02 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Andrew Saik
Sentiment: All, AUXL, EDGE, MNLO
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 02 2021 | MNLO | VYNE Therapeutics ... | Saik Andrew | Chief Financial Off ... | Payment of Exercise | F | 6.84 | 762 | 5,212 | 113,451 | 114.2 K to 113.5 K (-0.67 %) |
| Feb 24 2021 | MNLO | VYNE Therapeutics ... | Saik Andrew | Chief Financial Off ... | Option Exercise | A | 8.33 | 68,162 | 567,789 | 68,162 | |
| Feb 24 2021 | MNLO | VYNE Therapeutics ... | Saik Andrew | Chief Financial Off ... | Grant | A | 0.00 | 29,213 | 0 | 114,213 | 85 K to 114.2 K (+34.37 %) |
| Feb 24 2021 | MNLO | VYNE Therapeutics ... | Saik Andrew | Chief Financial Off ... | Option Exercise | A | 8.33 | 68,162 | 567,789 | 68,162 | |
| Feb 24 2021 | MNLO | VYNE Therapeutics ... | Saik Andrew | Chief Financial Off ... | Grant | A | 0.00 | 29,213 | 0 | 114,213 | 85 K to 114.2 K (+34.37 %) |
| Sep 08 2020 | MNLO | VYNE Therapeutics ... | Saik Andrew | Chief Financial Off ... | Buy | P | 1.46 | 40,000 | 58,480 | 340,000 | 300 K to 340 K (+13.33 %) |
| Sep 08 2020 | MNLO | VYNE Therapeutics ... | Saik Andrew | Chief Financial Off ... | Buy | P | 1.46 | 40,000 | 58,480 | 340,000 | 300 K to 340 K (+13.33 %) |